Pricing
  1. US-listed companies
  2. Emergent BioSolutions Inc.
  3. Financials
  4. FCF margin (%)

Emergent BioSolutions Inc. (EBS)

Market cap
$446.71M
P/E ratio
SummaryFinancials
Period EndFCF margin (%) YoY (%)
Dec 31, 20243.4-113.96%
Dec 31, 2023-24.6-0.83%
Dec 31, 2022-24.8-562.33%
Dec 31, 20215.4-78.89%
Dec 31, 202025.4+177.82%
Dec 31, 20199.1-336.04%
Dec 31, 2018-3.9-114.17%
Dec 31, 201727.3-686.76%
Dec 31, 2016-4.7+6799.21%
Dec 31, 2015-0.1-100.38%
Dec 31, 201317.6-448.72%
Dec 31, 2012-5-65.07%
Dec 31, 2011-14.4

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat